Telix Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $620,440 | $593,111 | $594,244 | $188,963 |
Gross Profit | 327,423 | 288,342 | 385,797 | 123,881 |
EBITDA | 28,924 | 8,905 | 76,800 | 40,291 |
EBIT | 11,034 | -1,762 | 78,795 | 36,631 |
Net Income | -7,252 | -3,482 | 38,239 | 11,680 |
Net Change In Cash | 620,440 | 593,111 | 594,244 | 188,963 |
Free Cash Flow | -92,598 | 16,836 | -5,684 | 30,381 |
Cash | 212,529 | 207,156 | 710,346 | 118,837 |
Basic Shares | 338,778 | 337,202 | 345,188 | 350,750 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,205,426 | $783,207 | $502,547 | $160,096 |
Gross Profit | 640,230 | 509,678 | 314,390 | 29,337 |
EBITDA | 79,831 | 98,233 | 22,966 | -92,837 |
EBIT | 47,166 | 92,547 | 16,223 | -98,216 |
Net Income | -10,685 | 49,919 | 5,211 | -104,079 |
Net Change In Cash | 1,205,426 | 783,207 | 502,547 | 160,096 |
Free Cash Flow | -82,795 | 28,707 | 14,205 | -71,008 |
Cash | 212,529 | 710,346 | 123,237 | 116,329 |
Basic Shares | 337,880 | 345,188 | 323,710 | 310,644 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.04 |
2025-09-30 | -$0.09 |
2025-06-30 | $0.01 |
2025-03-31 | $0.09 |
